Lectures
Management of Chronic Hypertension | Chalk Talks | TeachIM
Podcasts
#321 Hypertension FAQ: Common Outpatient Cases with Dr. Jordy Cohen - The Curbsiders
#474 Resistant Hypertension the Next Frontier - The Curbsiders
Resources
See table 13 in the 2025 AHA/ACC HTN guidelines for dosing of medications and considerations
Review this AAFP article about aldosteronism labs: primary-aldosteronism.pdf
Target: BP | Combined Quick Start Guide
From AHA and AMA with many resources about managing blood pressure. Includes webinars, assessments, summary of guidelines.
Guidelines
Articles
Hypertension - Clinical Practice Guideline | AAFP
ACCORD BP 2010: Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus | New England Journal of Medicine
P: Pts with T2DM at high risk for CV events
I: targeting SBP <120 mmHg
C: target SBP <140 mmHg
O: did not reduce rates of nonfatal MI, nofatal stroke, or CV mortality
SPRINT 2015: A Randomized Trial of Intensive versus Standard Blood-Pressure Control | New England Journal of Medicine
P: Pts high risk for CVD without hx of stroke or DM
I: targeting SBP <120 mmHg
C: target SBP 135-139 mmHg
O: Improved first ACS, stroke, HF or CV death (HR 0.75, 95%CI 0.64-0.89, NNT 63)
ADE: Hypotension NNH 100, AKI NNH 63
BPROAD 2024: Intensive Blood-Pressure Control in Patients with Type 2 Diabetes - PubMed
P: Pts with T2DM at high risk for CV events
I: targeting SBP <120 mmHg
C: target SBP <140 mmHg
O: did reduce rates of nonfatal MI, nonfatal stroke, HF, or CV mortality (HR 0.79, 95% CI 0.69-0.90)
Morning vs Night administration: